New Directions in the Pharmacotherapy of Posttraumatic Stress Disorder
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Psychiatric Quarterly
- Vol. 73 (4) , 259-270
- https://doi.org/10.1023/a:1020459916113
Abstract
Advances in psychopharmacology of PTSD are presented, focusing on antidepressants, adrenergic agents, antianxiety agents, and mood stabilizers. Treatment recommendations are related to recent...Keywords
This publication has 41 references indexed in Scilit:
- Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.2002
- Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2001
- Gabapentin in PTSD: A Retrospective, Clinical Series of Adjunctive Therapy1Annals of Clinical Psychiatry, 2001
- Fluvoxamine and sleep disturbances in posttraumatic stress disorderJournal of Traumatic Stress, 2001
- Cyproheptadine for Posttraumatic NightmaresAmerican Journal of Psychiatry, 2000
- The alpha1-Adrenergic Antagonist Prazosin Ameliorates Combat Trauma Nightmares in Veterans With Posttraumatic Stress DisorderThe Journal of Clinical Psychiatry, 2000
- Neurotransmitter alterations in PTSD: catecholamines and serotonin.1999
- Imipramine Treatment in Pediatric Burn Patients With Symptoms of Acute Stress Disorder: A Pilot StudyJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- NIGHTMARES TREATED WITH CYPROHEPTADINEJournal of the American Academy of Child & Adolescent Psychiatry, 1998
- Efficacy of Buspirone in the Treatment of Posttraumatic Stress Disorder: An Open TrialAnnals of Clinical Psychiatry, 1994